{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T17:25:09Z","timestamp":1791307509509,"version":"4.3.1"},"reference-count":20,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","ijaaonline.com","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1016\/j.ijantimicag.2015.12.002","type":"journal-article","created":{"date-parts":[[2015,12,21]],"date-time":"2015-12-21T07:31:56Z","timestamp":1450683116000},"page":"155-157","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Evaluation of antibiotic resistance to orally administrable antibiotics in staphylococcal bone and joint infections in one of the largest university hospitals in Germany: is there a role for fusidic acid?"],"prefix":"10.1016","volume":"47","author":[{"given":"Sabrina","family":"Klein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis","family":"Nurjadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatjana","family":"Eigenbrod","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konrad A.","family":"Bode","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2015.12.002_bib0105","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1056\/NEJMra040181","article-title":"Prosthetic-joint infections","volume":"351","author":"Zimmerli","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijantimicag.2015.12.002_bib0110","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1093\/jac\/dkt374","article-title":"Oral antibiotic treatment of staphylococcal bone and joint infections in adults","volume":"69","author":"Kim","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2015.12.002_bib0115","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/cis803","article-title":"Diagnosis and management of prosthetic joint infection: clinical practice guidelines by the Infectious Diseases Society of America","volume":"56","author":"Osmon","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2015.12.002_bib0120","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.medmal.2009.12.009","article-title":"Recommendations for bone and joint prosthetic device infections in clinical practice (prosthesis, implants, osteosynthesis). Soci\u00e9t\u00e9 de Pathologie Infectieuse de Langue Fran\u00e7aise","volume":"40","author":"Soci\u00e9t\u00e9 de Pathologie Infectieuse de Langue Fran\u00e7aise (SPILF)","year":"2010","journal-title":"Med Mal Infect"},{"key":"10.1016\/j.ijantimicag.2015.12.002_bib0125","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1093\/jac\/dkh191","article-title":"Antibiotic treatment of Gram-positive bone and joint infections","volume":"53","author":"Darley","year":"2004","journal-title":"J Antimicrob Chemother"},{"issue":"Suppl 2","key":"10.1016\/j.ijantimicag.2015.12.002_bib0130","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1016\/S0924-8579(98)00071-5","article-title":"Fusidic acid pharmacology, pharmacokinetics and pharmacodynamics","volume":"12","author":"Turnidge","year":"1999","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2015.12.002_bib0135","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ijantimicag.2012.03.010","article-title":"Fusidic acid for the treatment of bone and joint infections caused by meticillin-resistant Staphylococcus aureus","volume":"40","author":"Wang","year":"2012","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2015.12.002_bib0140","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1093\/jac\/dku174","article-title":"Emergence of trimethoprim resistance gene dfrG in Staphylococcus aureus causing human infection and colonization in sub-Saharan Africa and its import to Europe","volume":"69","author":"Nurjadi","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2015.12.002_bib0145","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1093\/jac\/dkp065","article-title":"Guidelines (2008) for the prophylaxis and treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in the United Kingdom","volume":"63","author":"Gould","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2015.12.002_bib0150","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1128\/AAC.02061-12","article-title":"Outcome of debridement and retention in prosthetic joint infections by methicillin-resistant staphylococci, with special reference to rifampin and fusidic acid combination therapy","volume":"57","author":"Peel","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2015.12.002_bib0155","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.2106\/00004623-199910000-00008","article-title":"Infection after total knee arthroplasty. A retrospective study of the treatment of eighty-one infections","volume":"81","author":"Segawa","year":"1999","journal-title":"J Bone Joint Surg Am"},{"key":"10.1016\/j.ijantimicag.2015.12.002_bib0160","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.2106\/00004623-200011000-00006","article-title":"Evaluation of preoperative cultures before second-stage reimplantation of a total knee prosthesis complicated by infection. A comparison-group study","volume":"82-A","author":"Mont","year":"2000","journal-title":"J Bone Joint Surg Am"},{"issue":"273","key":"10.1016\/j.ijantimicag.2015.12.002_bib0165","first-page":"98","article-title":"Effect of time of onset and depth of infection on the outcome of total knee arthroplasty infections","author":"Rasul","year":"1991","journal-title":"Clin Orthop Relat Res"},{"key":"10.1016\/j.ijantimicag.2015.12.002_bib0170","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/jac\/39.2.235","article-title":"Oral treatment of Staphylococcus spp. infected orthopaedic implants with fusidic acid or ofloxacin in combination with rifampicin","volume":"39","author":"Drancourt","year":"1997","journal-title":"J Antimicrob Chemother"},{"issue":"Suppl 2","key":"10.1016\/j.ijantimicag.2015.12.002_bib0175","doi-asserted-by":"crossref","first-page":"S79","DOI":"10.1016\/S0924-8579(98)00077-6","article-title":"Fusidic acid in bone and joint infections","volume":"12","author":"Atkins","year":"1999","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2015.12.002_bib0180","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1128\/AAC.50.1.55-61.2006","article-title":"Multiple combination bactericidal testing of staphylococcal biofilms from implant-associated infections","volume":"50","author":"Saginur","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"issue":"Suppl 7","key":"10.1016\/j.ijantimicag.2015.12.002_bib0185","doi-asserted-by":"crossref","first-page":"S527","DOI":"10.1093\/cid\/cir168","article-title":"The safety record of fusidic acid in non-US markets: a focus on skin infections","volume":"52","author":"Kraus","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2015.12.002_bib0190","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1179\/joc.2008.20.5.645","article-title":"In vitro release of fusidic acid and teicoplanin from cancellous bone allografts","volume":"20","author":"Kanellakopoulou","year":"2008","journal-title":"J Chemother"},{"key":"10.1016\/j.ijantimicag.2015.12.002_bib0195","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1093\/cid\/cir842","article-title":"Systemic antibiotic therapy for chronic osteomyelitis in adults","volume":"54","author":"Spellberg","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2015.12.002_bib0200","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0006-2952(02)01015-8","article-title":"Inhibition of transport across the hepatocyte canalicular membrane by the antibiotic fusidate","volume":"64","author":"Bode","year":"2002","journal-title":"Biochem Pharmacol"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857915004057?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857915004057?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,16]],"date-time":"2018-09-16T18:52:43Z","timestamp":1537123963000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857915004057"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":20,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["S0924857915004057"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2015.12.002","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2016,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of antibiotic resistance to orally administrable antibiotics in staphylococcal bone and joint infections in one of the largest university hospitals in Germany: is there a role for fusidic acid?","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2015.12.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved.","name":"copyright","label":"Copyright"}]}}